Research Greatest Hits- Updates in Buprenorphine Treatment Practices in Opioid Use Disorders-View Presentation

Video Transcription

Video Summary

In this webinar on improving medications for opioid use disorder practices, Dr. Mark Fishman presented on various topics. He highlighted the need to address major statistics associated with poor treatment outcomes, such as stimulant use, younger age, criminal justice involvement, and homelessness. Efforts should be made to offer medication for opioid use disorder (MOUD) in jails, with a focus on linking individuals to treatment upon release. Dr. Fishman emphasized the importance of using MOUD for patients with co-occurring substance use disorders, as it is safe and effective. He also discussed dosing strategies for buprenorphine and methadone, recommending rapid dose increases and dynamic dosing for maximum effectiveness. Finally, he touched on the challenges of offering extended-release naltrexone to opioid-dependent patients and suggested exploring strategies to increase its desirability and acceptability.

Keywords

improving medications

opioid use disorder practices

Dr. Mark Fishman

stimulant use

younger age

criminal justice involvement

homelessness

medication for opioid use disorder

MOUD